[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1340507T3 - Anvendelse af et fibroblastvækstfaktor-bindingsprotein til behandling og diagnosticering af diabetiske sårhelingsforstyrrelser - Google Patents

Anvendelse af et fibroblastvækstfaktor-bindingsprotein til behandling og diagnosticering af diabetiske sårhelingsforstyrrelser

Info

Publication number
DK1340507T3
DK1340507T3 DK02004299T DK02004299T DK1340507T3 DK 1340507 T3 DK1340507 T3 DK 1340507T3 DK 02004299 T DK02004299 T DK 02004299T DK 02004299 T DK02004299 T DK 02004299T DK 1340507 T3 DK1340507 T3 DK 1340507T3
Authority
DK
Denmark
Prior art keywords
diagnosis
treatment
growth factor
binding protein
fibroblast growth
Prior art date
Application number
DK02004299T
Other languages
English (en)
Inventor
Andreas Goppelt
Michaela Bittner
Original Assignee
Switch Biotech Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Switch Biotech Ag filed Critical Switch Biotech Ag
Application granted granted Critical
Publication of DK1340507T3 publication Critical patent/DK1340507T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02004299T 2002-02-28 2002-02-28 Anvendelse af et fibroblastvækstfaktor-bindingsprotein til behandling og diagnosticering af diabetiske sårhelingsforstyrrelser DK1340507T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02004299A EP1340507B1 (de) 2002-02-28 2002-02-28 Verwendung eines Fibroblastenwachstumsfaktor-Bindeproteins zur Behandlung und Diagnose von diabetischen Wundheilugnsstörungen

Publications (1)

Publication Number Publication Date
DK1340507T3 true DK1340507T3 (da) 2005-02-28

Family

ID=27675637

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02004299T DK1340507T3 (da) 2002-02-28 2002-02-28 Anvendelse af et fibroblastvækstfaktor-bindingsprotein til behandling og diagnosticering af diabetiske sårhelingsforstyrrelser

Country Status (4)

Country Link
EP (1) EP1340507B1 (da)
AT (1) ATE276755T1 (da)
DE (1) DE50201092D1 (da)
DK (1) DK1340507T3 (da)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU215581B (hu) * 1989-07-06 1999-01-28 Regents Of The University Of California Eljárás fibroblaszt növekedési faktor receptorok előállítására és terápiás alkalmazására
US5229501A (en) * 1991-01-11 1993-07-20 Chiron Corporation Expression and use of human fibroblast growth factor receptor
WO2000005416A2 (en) * 1998-07-23 2000-02-03 Georgetown University Fgf-bp promoter sequences as sensors of drug effects
CA2361293A1 (en) * 1999-02-10 2000-08-17 Human Genome Sciences, Inc. 33 human secreted proteins

Also Published As

Publication number Publication date
ATE276755T1 (de) 2004-10-15
EP1340507B1 (de) 2004-09-22
EP1340507A1 (de) 2003-09-03
DE50201092D1 (de) 2004-10-28

Similar Documents

Publication Publication Date Title
EA200600869A1 (ru) Антитела, связывающие рецептор интерлейкина-4
ATE356607T1 (de) Verwendung von nativem zein zur verbesserung des haarzustandes und mittel
WO2007024899A3 (en) Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
SI1583774T1 (sl) Postopki za preprečevanje in zdravljenje Alzheimerjeve bolezni AD
ATE444967T1 (de) Spezifische bindungsmittel von human angiopoietin-2
WO2006114105A8 (en) Use of modified factor vii for treating bleeding
SE9603533D0 (sv) Specific peptides for the treatment of deabetes mellitus
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
WO2006135493A3 (en) A composition for wound healing and use thereof
WO2003039591A3 (de) Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
DE50009838D1 (de) Humanes antibiotisches protein
WO2006004675A3 (en) Production of tissue factor in plants
DK1340507T3 (da) Anvendelse af et fibroblastvækstfaktor-bindingsprotein til behandling og diagnosticering af diabetiske sårhelingsforstyrrelser
WO2004113386A3 (en) Modified hirudin proteins and t-cell epitopes in hirudin
HUP0300923A2 (hu) RAF és RAS protein kinázt tartalmazó készítmények és alkalmazásuk angiogenezis módosítására
WO2002014369A3 (en) Human kininogen d5 domain polypeptides and their use
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
DE60316209D1 (de) Verwendung von Ascorbinsäure zur Verstärkung der dermo-epidermischen Bindung
DE502004012439D1 (de) Medikament und verwendung zur tumortherapie
AR062762A1 (es) Metodos para promover la vascularizacion colateral sin fugas
TW200635950A (en) Specific binding agents of human angiopoietin-2